Financhill
Back

Immunovant Stock Price Chart

Don't put a penny in AI stocks until you read this

Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
54

IMVT
Immunovant

Last Price:
29.29
Seasonality Move:
35.41%

7 Day Trial

ALL ACCESS PASS

$ 7

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Immunovant Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 29.57 Sell
20-day SMA: 29.18 Sell
50-day SMA: 29.99 Sell
200-day SMA: 31.3 Sell
8-day EMA: 29.39 Sell
20-day EMA: 29.45 Sell
50-day EMA: 29.53 Sell
200-day EMA: 29.72 Sell

Immunovant Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 47.94 Sell
Chaikin Money Flow: 1531714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.53 - 29.83) Sell
Bollinger Bands (100): (26.8 - 30.74) Buy

Immunovant Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Immunovant Stock

Is Immunovant Stock a Buy?

  • Immunovant share price is 29.17 while IMVT 8-day simple moving average is 29.57, which is a Sell signal.
  • The stock price of IMVT is 29.17 while Immunovant 20-day SMA is 29.18, which makes it a Sell.
  • Immunovant 50-day simple moving average is 29.99 while IMVT share price is 29.17, making it a Sell technically.
  • IMVT stock price is 29.17 and Immunovant 200-day simple moving average is 31.30, creating a Sell signal.

IMVT Technical Analysis vs Fundamental Analysis

Buy
54
Immunovant (IMVT) is a Buy

Is Immunovant a Buy or a Sell?

  • Immunovant stock is rated a Buy
    The current Immunovant [IMVT] share price is $29.17. The Score for IMVT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.

Immunovant Stock Info

Market Cap:
4.27B
Price in USD:
29.17
Share Volume:
2.08M

Immunovant 52-Week Range

52-Week High:
45.58
52-Week Low:
24.67
Buy
54
Immunovant (IMVT) is a Buy

Immunovant Share Price Forecast

  • What is the Immunovant stock price today?
    The Immunovant stock price is 29.17 USD today.
  • Will IMVT stock go up or go down?
    Immunovant> share price is forecast to RISE/FALL based on technical indicators
  • Is Immunovant overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immunovant is not overvalued.

Is Immunovant Stock a Buy?

  • Immunovant share price is 29.17 while IMVT 8-day exponential moving average is 29.39, which is a Sell signal.
  • The stock price of IMVT is 29.17 while Immunovant 20-day EMA is 29.45, which makes it a Sell.
  • Immunovant 50-day exponential moving average is 29.53 while IMVT share price is 29.17, making it a Sell technically.
  • IMVT stock price is 29.17 and Immunovant 200-day simple moving average is 29.72, creating a Sell signal.

Fundamental Analysis of Immunovant

Is Immunovant a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.66 per share.

Technical Analysis of Immunovant

Should I short Immunovant stock?

  • IMVT Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Immunovant is a Sell
  • Immunovant Relative Strength Index (RSI) is 47.94, which suggest Immunovant is oversold
  • The Bollinger Bands (25) for Immunovant is (28.53 - 29.83), which suggest Immunovant is a Buy
  • The Bollinger Bands (100) for Immunovant is (26.8 - 30.74), which suggest Immunovant is a Buy

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.